Target intelligence / Profile preview

Pre-let-7f microRNA (pre-let-7f)

Target
pre-let-7f
Molecular classification
Non-coding RNA, microRNA, Precursor microRNA
01

Overview

Pre-let-7f is a precursor microRNA (pre-miRNA) that serves as the intermediate in the biogenesis of mature let-7f, a key member of the highly conserved lethal-7 (let-7) microRNA family (Wikipedia, 2024). It is characterized by a hairpin-loop structure that is recognized and cleaved by the Dicer enzyme in the cytoplasm to produce the functional 22-nucleotide mature miRNA (NIH, 2024). Let-7f functions as a potent tumor suppressor by binding to the 3-untranslated regions (UTRs) of various oncogenic mRNAs, including RAS, MYC, and HMGA2, thereby inhibiting their translation or promoting their degradation (NIH, 2024; MDPI, 2021). In many human cancers, the biogenesis of let-7f is actively suppressed by the RNA-binding proteins Lin28A and Lin28B, which bind to the terminal loop of pre-let-7f and recruit terminal uridylyltransferases (TUTases) to induce its degradation (NIH, 2024; Molecular Cell, 2008). This Lin28/let-7 axis is a significant therapeutic target, with drug development efforts focusing on small-molecule inhibitors that disrupt the Lin28-pre-miRNA interaction to restore tumor-suppressive let-7 levels (NIH, 2024; Grantome, 2024). Additionally, synthetic let-7 mimics are being explored as replacement therapies to bypass the biogenesis blockade and suppress tumor growth and metastasis (NIH, 2024).

Other names
MIR7F1MIR7F2hsa-let-7f-1hsa-let-7f-2Mirlet7f-1Mirlet7f-2MicroRNA let-7f precursor
02

Mechanism of action

Restoration of tumor suppressor function; Inhibition of miRNA biogenesis; Prevention of Lin28-mediated degradation and uridylation

03

Biological functions

Gene silencingCell differentiationTumor suppressionDevelopmental timing regulationStem cell maintenanceImmune response regulation
04

Disease associations

Cancer (e.g., Glioma, Ovarian, Breast, Leukemia)InflammationInfectious disease (e.g., Tuberculosis)Endometriosis
05

Safety considerations

Off-target gene silencingRNA delivery efficiencyInnate immune response to exogenous RNAPotential for systemic toxicity due to multi-gene targeting
06

Interacting drugs

Kanamycin A

3 more in the full profile.

07

Biomarkers

let-7f expression levelsLin28A/B expressionHMGA2 expressionRAS expression

Beyond the preview

Go deeper on Pre-let-7f microRNA (pre-let-7f).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-let-7f microRNA (pre-let-7f).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call